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Abstract
OBJECTIVE: To determine the mechanisms by
which Kangxianling (KXL) treats renal interstitial fi-
brosis using a customized gene chip.
METHODS: Twelve out of 18 specific patho-
gen-free sprague dawley (SPF SD) rats underwent a
unilateral ureteral occlusion. These rats were then
randomly assigned into either the model unilateral
ureteral obstruction (UUO) or Kangxianling( KXL)
group. The other six rats were assigned to the
sham-operated group. The UUO and sham-operat-
ed groups were given normal saline via intragastric
administration, whereas the KXL group was given
KXL via intragastric administration. All rats were sac-
rificed for renal tissue collection (i.e. left nephridial
tissue), and the detection of genetic changes with
the customized chip.
RESULTS: Compared to the sham-operated group,
transforming growth factor-β1 (TGF-β1), Smad2,
and Smad3 genes were significantly up-regulated
in the UUO group, with >1.5-fold rise (P<0.01). The
Smad7 gene was significantly reduced in the UUO
versus sham-operated group, with a down-regula-
tion of >1.5-fold (P<0.01). In the KXL group, TGF-β1,
Smad2, and Smad3 genes were significantly re-
duced compared to the UUO group, with a
down-regulation of >1.5-fold (P<0.01), whereas the
Smad7 gene was significantly increased compared
to the UUO group, with an up-regulation of >
1.5-fold (P<0.01).
CONCLUSION: It was found that KXL can signifi-
cantly reduce the gene levels of TGF-β1, Smad2,
and Smad3. Immunohistochemistry findings also
revealed significantly lower TGF-β1/Smads-mediat-
ed gene transcription activity. These findings sug-
gest that KXL may negatively regulate the TGF-β1/
Smads signal pathway to inhibit the occurrence of
renal fibrosis.
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INTRODUCTION
Kangxianling (KXL) granule is a Chinese herbal com-
pound clinically proven to be effective for the treat-
ment of early and mid-stage renal fibrosis via
long-term practice at the Department of Nephrology,
Shuguang Hospital Affiliated to Shanghai University of
TCM. Many years of clinical practice revealed that
KXL has a positive effect in preventing and curing
chronic kidney disease[1-5]. It can significantly improve
renal function and quality of life for patients with
chronic kidney disease. A series of studies[6-9] demon-
strated that KXL can inhibit the development of chron-
ic kidney disease via systemic therapeutic effects. KXL
induces is therapeutic effects by improving proteinuria
and lipid metabolism, as well as chronic glomerular
sclerosis. KXL can reduce renal fibrosis in animal mod-
els, as well as inflammatory cell infiltration and extra-
cellular matrix accumulation. Previous findings suggest
that KXL has a multi-channel, multi-target, and
multi-gene mechanism of action. Based on previous
studies, there may be mechanisms by which KXL inhib-
its renal fibrosis that affect a group of related genes,
which may result in a variety of cell function changes
that: 1) inhibit tubular epithelial cell (TEC) apoptosis;
2) block fibroblasts and their phenotypic switch into
myofibroblasts; 3) inhibit the influx and/or prolifera-
tion of lymphocytes/macrophages, fibrocytes (circulat-
ing fibroblast precursors), and fibroblasts; and 4) re-
duce the epithelial-to-mesenchymal transition (EMT)
of TECs. A customized array gene chip was used to in-
vestigate the mechanisms by which KXL inhibits renal
fibrosis in early and mid-stage chronic kidney disease.
MATERIALS ANDMETHODS
Animals
Eight-week old, male Sprague-Dawley (SD) rats,
weighing 180±20 g, were supplied by the Center of Ex-
perimental Animals, Shanghai University of Traditional
Chinese Medicine. The experimental animal license
number was SYXK (HU) 2004-0005 and the certifi-
cate number was 0058668. The animals were kept in a
specific pathogen-free environment. The experiments
were performed according to the institutional guide-
lines and were approved by the Shanghai University of
Traditional Chinese Medicine.
Renal interstitial fibrosis induced by UUO
UUO or sham surgery was performed under 3% pento-
barbital sodium anesthesia. The left ureter was ligated
with 4-0 silk at two points, and then severed between
the ligatures to prevent retrograde urinary tract infec-
tion. The control rats underwent a sham-operation.
The animals were sacrificed one week later via exsan-
guination through a cardiac puncture under general an-
esthesia. The left kidneys were harvested and sectioned
longitudinally. Half of the kidney was snap frozen im-
mediately for gene analysis, and the other half was for-
malin-fixed and paraffin-embedded for immunohisto-
chemical analyses.
Main reagents
The cell and tissue total protein extraction kit
(KangChen, KC-415), BCA protein assay kit
(KangChen, KC-430), and biotin-labeled protein mo-
lecular weight standards (KangChen, KC-410) were
purchased from KangChen (Shanghai, China) The rab-
bit anti-rat CHIP antibody were purchased from Santa
Cruz (CA). The rabbit anti-rat TGF-β1, smad2,
smad3, and smad7 antibodies were purchased from Ab-
cam (UK). The horseradish peroxidase (HRP) combi-
nation of two antibodies and beta-actin antibody were
obtained from the Shanghai Zhaorui Bio-Engineering
Company (Shanghai, China).
Reverse transcriptase 2 (RT2), ribonucleic acid (RNA),
quantitative competitive (QC), polymerase chain reac-
tion (PCR) Arrays.
Tissue from the left kidney underwent RNA isolation,
isolation of small quantity RNA, RNA clean up, assess-
ments of RNA yield and quality, concentration and pu-
rity measurements, denaturing agarose gel electrophore-
sis, first strand cDNA synthesis; real-time PCR, and da-
ta analysis using the ΔΔCt method. Specifically, theΔCt was calculated for each pathway-focused gene in
each experimental group, where ΔCt (group 1) =aver-
age Ct - average of HK genes' Ct in the control group
(group 1) array, and ΔCt (group 2)=average Ct - aver-
age of HK genes' Ct in the experimental group (group
2) array. Then, ΔΔCt was calculated for each gene
across the two PCR Arrays (or groups) using the fol-
lowing equation: ΔΔCt=ΔCt (group 2)－ΔCt (group
1), where group 1 is the control and group 2 is the ex-
perimental group. The fold-change was calculated for
each gene from group 1 to group 2 as 2-ΔΔCt. If the
fold-change was greater than 1, the result was reported
as a fold up-regulation. If the fold-change was less than
1, the result was reported as a fold down-regulation.
The experiment was repeated five times. The criteria
adopted were in accordance with international practic-
es. A P-value less than 0.05, and a fold-change greater
than 1 or less than 1 were considered statistically signif-
icant.
Immunohistochemical analyses
A portion of the kidney tissue was excised promptly af-
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ter the animals were sacrificed, and immediately placed
into 10% neutral-buffered formalin. The tissue was
fixed overnight in formalin, processed for paraffin em-
bedding following standard protocols, and then sec-
tioned for antibody staining. Staining for TGF-β1,
Smad2, Smad3, and Smad7 was performed after the
sections were deparaffinized and hydrated. Heat-in-
duced antigen retrieval was performed using 5 mM of
ethylenediaminetetra-acetic acid (EDTA) solution
(pH=8.0) and 10 mM of citrate solution (pH=6.0) at
25 psi for 2 min in a decloaking chamber. Non-specific
staining was blocked using Sniper (Biocare Medical,
Concord, CA, USA) for 9 min. Slides were incubated
overnight with TGF-β1, Smad2, Smad3, and Smad7,
and then washed and incubated with 3% hydrogen per-
oxide for 30 min. A HRP polymer detection system
and 3, 3'-diaminobenzidine (DAB) substrate were used
to tag and stain the first primary antibody brown. The
tissue sections were washed in distilled water, counter-
stained with hematoxylin, dehydrated through an etha-
nol series, and mounted with cover slips. Cortical stain-
ing intensity was scored on a scale of 0-3, where 0 indi-
cated no staining, 1 indicated mild staining, 2 indicat-
ed moderate staining, and 3 indicated intense staining
for TGF-β1, Smad2, Smad3, and Smad7. Five high
magnification fields were evaluated, and the results
were expressed as mean±standard error.
Statistical analyses
Data are expressed as mean±SD. Data were analyzed us-
ing one-way analysis of variance (ANOVA) test for
comparisons, and a P<0.05 was considered statistically
significant. Statistical analyses were performed with
GraphPad Prism 5.0 (GraphPad, San Diego, CA).
RESULTS
Key regulatory genes of renal interstitial fibrosis
detected with a customized array
The key regulatory genes included 84 genes that are
primarily involved in the dogma signaling pathway re-
lated to renal interstitial fibrosis. In the UUO model
group, four genes were screened and found to be signif-
icant. Specifically, TGF-β1, Smad2, and Smad3, which
are responsible for promoting fibrosis, and Smad7,
which is responsible for inhibiting fibrosis, were identi-
fied. After KXL treatment, TGF-β1, Smad2, and
Smad3 were down-regulated by >1.5-fold, whereas
Smad7 was up-regulated by >1.5-fold. (Table 1 and
Figure 1). Thus, KXL not only down-regulates fibro-
sis-promoting genes, but also up-regulates fibrosis-in-
hibiting gene, suggesting that it has multi-target,
multi-role characteristics.
Immunohistochemistry
Using a customized array, it is found that the genes in-
volved in renal interstitial fibrosis were TGF-β1,
Smad2, and Smad3, which are the fibrosis-promoting
genes, and Smad7, which are the fibrosis-inhibiting
genes. Additionally, using immunohistochemistry, the
protein expression of these genes was consistent with
the results of the customized array chip. Differences in
TGF-β1 expression between the UUO group and
sham-operated group were significant (P<0.01), and
differences in TGF-β1 expression between the KXL
group and UUO group were also significant (P<0.05).
The expressions of the corresponding genes involved in
the TGF-β1/Smads signaling pathway regulating
genes, specifically, Smad2 and Smad3, were significant-
ly up-regulated in the UUO group. Differences in
Smad2 and Smad3 expressions between the UUO
group and sham-operated group were significant (P<
0.01), and the differences between KXL group and
UUO group were also significant (P<0.05). While the
expression of the anti-fibrosis gene, Smad7, significant-
ly decreased in the UUO group, it was significantly in-
creased in the KXL group. Differences in Smad 7 ex-
pression between the UUO group and sham-operated
group was significant (P<0.01), and differences be-
tween the KXL group and UUO group were also signif-
icant (P<0.01) (Figure 2).
In Table 1 and Figure 1, it is evident that both the
KXL and UUO groups demonstrated significant differ-
ences in the expression patterns of the four genes.
Compared to the UUO group, TGF-β1, Smad2, and
Smad3 were down-regulated >1.5-fold, whereas Smad7
was up-regulated 1.5-fold (P<0.01). Comparing the
UUO group to the sham-operated group, TGF-β1,
Smad2, and Smad3 gene expression increased 1.5-fold,
whereas Smad7 was down-regulated >1.5-fold (P<
0.01).
Table 1 Comparisons of gene expression levels in UUO
Genebank
accession No.
NM_021578
NM_019191
NM_013095
NM_030858
Gene
symbol
Tgfb1
Smad2
Smad3
Smad7
Fold up- or down-regulation
UUO/ SHAM
3.80
4.92
6.52
-4.30
KXL/UUO
﹣2.14
﹣1.69
﹣2.14
1.81
Notes: If the fold change is positive, then the gene was up-regulated. If the fold change was negative, then the gene was down-regulated.
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Figure 1 Comparisons of gene fold up-regulation or down-regulation via a 3D profile and scatter plot.
Figure 2 Protein expression levels of TGF-β1, Smad2, Smad3, and Smad7. *P<0.01, UUO vs. Sham; #P<0.05, UUO vs. KXL; and ##P<
0.05, UUO vs. KXL.
DISCUSSION
Unilateral ureteral obstruction fits into the category of
kidney collateral disease in TCM, and its pathogenesis
is considered to be a result of a deficiency in origin and
excess in superficiality. This condition exhibits the in-
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ternal accumulation of dampness, heat, blood stasis,
and toxin. Thus, treatment should focus on both the
root and branch aspects, supporting healthy qi and re-
moving pathogenic factors. KXL is composed of radix
salviae miltiorrhiae (Dan Shen), prepared rhubarb (Zhi-
Da Huang), angelica (Dang Gui), Achyranthes (Niu
Xi), and peach kernel (Tao Ren). It has obvious cura-
tive effects on activating blood and removing blood sta-
sis, reinforcing body resistance, and eliminating poi-
sons to restore the renal function. Miltiorrhiae (Dan
Shen), angelica (Dang Gui), achyranthes (Niu Xi), and
peach kernel (Tao Ren) are used to strengthening body
resistance and promote blood circulation by removing
blood stasis, and rhubarb is used for reinforcement and
elimination. Previous research confirmed that KXL can
inhibit renal tissue TGF-β1 over-expression in rats
with chronic renal failure, reduce the accumulation of
ECM to improve glomerular sclerosis, and reduce the
glomerular cell apoptosis index[1-3]. KXL can also inhib-
it protein and fiber coupling type IV collagen in renal
tissue with excessive sedimentation, improve the glo-
merular sclerosis index, and decrease angiotensin I and
II, laminin, type III collagen, and tumor necrosis fac-
tor-α. It can decrease proteinuria and adjust lipid me-
tabolism to suppress renal fibrosis and improve renal
function [4-7]. In order to accurately understand the role
of KXL, "signal pathway finder" (Pathway Finder)
gene chips, designed by the SuperArray Bioscience Cor-
poration, were used. Using customized arrays, it was
found that the TGF-β1/Smads signaling pathway was
significantly affected by KXL. That is, KXL is capable
of regulating TGF-β1, Smad2, Smad3, and Smad7 in
EMT and kidney fibrosis.
Using the customized array, it was found that TGF-β1,
Smad2, and Smad3 were up-regulated by >1.5-fold,
and Smad7 was down-regulated by >1.5-fold in the
UUO group. These genes are closely related to the oc-
currence of renal fibrosis (Figure 1, Table 1). The
UUO rat model of renal interstitial fibrosis is mediated
via the TGF-β/Smads signaling pathway. Thus, KXL
was not only involved in the regulation of fibrosis
genes, specifically, TGF-β1, Smad2, and Smad3, but
an anti-fibrosis gene, Smad7[8,9]. In the present study,
we found that TGF-β1, Smad2, and Smad3 protein
levels were significantly reduced, and Smad7 was signif-
icantly increased, in the KXL group (Figure 2). These
findings suggest that KXL influences the levels of
Smads proteins to regulate the TGF-β signaling path-
way, and inhibit renal fibrosis. To further confirm that
KXL can regulate TGF-β1, Smad2, Smad3, and
Smad7, which play a vital role in anti-fibrosis, we veri-
fied TGF-β1, Smad2, Smad3, and Smad7 protein ex-
pression via immunohistochemistry. The findings from
the immunohistochemistry experiments were consis-
tent with the data from the customized array (Figure
2). Thus, KXL acts via the inhibitory TGF-β signaling
pathway to inhibit kidney fibrosis. Our findings are of
great importance in the understanding of the molecu-
lar mechanisms involved in inhibiting renal fibrosis.
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